Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 4 Planned sale Chief Executive Officer sold 51,726 shares at an average $69.13 ($3,575,575)
  4. 4 Planned sale Director sold 7,530 shares at $70.00 ($527,100)
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 4 Planned sale Director sold 8,367 shares at an average $67.65 ($566,038)
  8. 4 Planned sale Director sold 10,040 shares at an average $67.68 ($679,491)
  9. 4 Planned sale Chief Executive Officer sold 26,031 shares at an average $68.04 ($1,771,022)
  10. 4 Planned sale Director sold 10,000 shares at an average $67.66 ($676,623)
  11. 144 Insider Sale of Securities
  12. 4 Open-market sale Chief Executive Officer sold 85,000 shares at an average $64.04 ($5,443,462)
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 4 Grant or award Director acquired 7,819 shares (grant or award)
  18. 4 Grant or award Director acquired 7,819 shares (grant or award)
  19. 4 Grant or award Director acquired 7,819 shares (grant or award)
  20. 4 Grant or award Director acquired 7,819 shares (grant or award)

Page 4 of 69 · 1,363 filings